92 related articles for article (PubMed ID: 17445990)
1. Oxidative damage of 14-3-3 zeta and gamma isoforms in Alzheimer's disease and cerebral amyloid angiopathy.
Santpere G; Puig B; Ferrer I
Neuroscience; 2007 Jun; 146(4):1640-51. PubMed ID: 17445990
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease.
Perez-Gracia E; Blanco R; Carmona M; Carro E; Ferrer I
Acta Neuropathol; 2009 Oct; 118(4):497-504. PubMed ID: 19597827
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.
Miners JS; Ashby E; Van Helmond Z; Chalmers KA; Palmer LE; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):181-93. PubMed ID: 17973905
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
Attems J; Jellinger KA; Lintner F
Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
[TBL] [Abstract][Full Text] [Related]
5. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
Attems J; Jellinger KA
Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
[TBL] [Abstract][Full Text] [Related]
6. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.
Jiang ZJ; Richardson JS; Yu PH
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):194-204. PubMed ID: 17971074
[TBL] [Abstract][Full Text] [Related]
7. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
8. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.
Tian J; Shi J; Smallman R; Iwatsubo T; Mann DM
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):332-40. PubMed ID: 16640651
[TBL] [Abstract][Full Text] [Related]
9. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Williams S; Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
[TBL] [Abstract][Full Text] [Related]
11. Cerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study.
Xu D; Yang C; Wang L
Acta Neuropathol; 2003 Jul; 106(1):89-91. PubMed ID: 12698265
[TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease.
Thal DR; Griffin WS; de Vos RA; Ghebremedhin E
Acta Neuropathol; 2008 Jun; 115(6):599-609. PubMed ID: 18369648
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
[TBL] [Abstract][Full Text] [Related]
14. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
Castellani RJ; Smith MA; Perry G; Friedland RP
Neurobiol Aging; 2004; 25(5):599-602; discussion 603-4. PubMed ID: 15172735
[TBL] [Abstract][Full Text] [Related]
15. Contributors to white matter damage in the frontal lobe in Alzheimer's disease.
Chalmers K; Wilcock G; Love S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):623-31. PubMed ID: 16281911
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-β19 expressed in cerebral amyloid angiopathy.
Tanskanen M; Myllykangas L; Saarialho-Kere U; Paetau A
Amyloid; 2011 Mar; 18(1):3-9. PubMed ID: 21261556
[TBL] [Abstract][Full Text] [Related]
17. [Genetic factors for cerebral amyloid angiopathy].
Hamaguchi T; Yamada M
Brain Nerve; 2008 Nov; 60(11):1275-83. PubMed ID: 19069161
[TBL] [Abstract][Full Text] [Related]
18. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
19. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques.
Kumar-Singh S
Genes Brain Behav; 2008 Feb; 7 Suppl 1():67-82. PubMed ID: 18184371
[TBL] [Abstract][Full Text] [Related]
20. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.
Baig S; Kehoe PG; Love S
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):205-15. PubMed ID: 17971072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
